Coronavirus (COVID-19) Vaccine Resources

There are three vaccines available in the U.S. The Pfizer-BioNTech vaccine is FDA-authorized for ages 5-15 and FDA approved for ages 16 and older. The Moderna^® and Johnson & Johnson^® vaccines are FDA-authorized for ages 18 and older.

Yes, as of October 29, 2021, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for children five through 11 years of age.

• The vaccine was found to be 90.7% effective in preventing COVID-19 in children five through 11 years of age.
• Safety: The vaccine’s safety was studied in approximately 3,100 children age five through 11 years who received the vaccine. No serious side effects have been detected in the ongoing study.

The Pfizer-BioNTech COVID-19 Vaccine for children five through 11 years of age is administered as a two-dose primary series, three weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30 micrograms).

If you are a parent or guardian with questions about the vaccine, we encourage you to talk with your child’s health care provider.

For more information you can read:

• The FDA decision to authorize the use of the Pfizer-BioNTech COVID-19 vaccine for 5-11 year olds
• CDC Recommends Vaccine for Kids ages 5-11

Cigna looks to the U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and input from the Advisory Committee on Immunization Practices (ACIP) to determine these factors.

It has been shown that all three COVID-19 vaccines currently available in the United States are highly effective at preventing COVID-19.

To learn more about the vaccines, visit:

Different COVID-19 Vaccines | CDC

Vaccines | FDA

There are now booster recommendations for all three available COVID-19 vaccines in the United States. Eligible individuals may choose which vaccine they receive as a booster dose. Some people may have a preference for the vaccine type that they originally received, and others may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.

For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot at six months or more after their initial series:

• 65 years and older
• Age 18+ who live in long-term care settings
• Age 18+ who have underlying medical conditions
• Age 18+ who work or live in high-risk settings

For the nearly 15 million people who got the Johnson & Johnson COVID-19 vaccine, booster shots are also recommended for those who are 18 and older and who were vaccinated two or more months ago.

For the latest recommendations on eligibility of booster shots, including recommendations for the general population, refer to the CDC’s COVID-19 Vaccine Booster Shot Eligibility or talk to your health care provider.

Yes, you should be vaccinated regardless of whether you already had COVID-19 because:

• Research has not yet shown how long you are protected from getting COVID-19 again after you recover from COVID-19.
• Vaccination helps protect you even if you’ve already had COVID-19.

If you are in a position where you can choose your healthcare provider (e.g. non-emergency), we recommend using the provider directory available on myCigna.com or the myCigna^® mobile app to find an in-network provider. You can also call the phone number on your ID card to find in-network health care providers to eliminate any risk your provider may choose to bill above these rates.

Some people suffer from ongoing or new symptoms after a diagnosis of COVID-19. Recovery could take as long as or longer than 3 months. It is important to see your Primary Care Provider (PCP) to discuss ongoing COVID-19 symptoms and an appropriate treatment plan. If you don’t have a PCP, log in to myCigna and use the provider directory to find an in-network provider. For more information, visit Post-COVID Conditions | CDC

After you recover from COVID-19 and/or return home from a hospitalization, your PCP can determine the best treatment plan, including assessing any follow care needed. Continue to take ensure you are up to date with preventative care screenings.

The FDA recently authorized the monoclonal antibody therapy, REGEN-COV^TM, for emergency use as post-exposure prevention of COVID-19 for those 12 years of age and older weighing at least 88 pounds who are at high risk for progression to severe COVID-19, including hospitalization or death.

REGEN-COV also remains authorized for the treatment of mild-to-moderate COVID-19 for those who are at high-risk for progression to severe COVID-19. Your PCP is the best person to discuss whether this therapy is appropriate for you.

To find locations that may be able to provide monoclonal antibody therapeutic treatments visit:

The U.S. Department of Health and Human Services (HHS) outpatient antibody treatment locator tool

The National Infusion Center Association^SM

Yes. Cigna has partnered with Access2Care^SM (A2C) to provide our Medicare Advantage customers with four one-way trips to get their COVID-19 vaccine at no additional cost. A trip is defined as a one-way ride that’s under 60 miles from start to finish.

• If your plan includes transportation, we’ve added four more one-way trips to get the COVID-19 vaccine.
• If your plan does not include transportation, we’re providing you with four one-way trips to get the COVID-19 vaccine.

At this time, transportation to drive-through vaccine sites/events is not available in order to maintain patient privacy and safety.

Once you have a vaccination appointment, you can schedule your free rides. Call the A2C (Access2Care) customer service number for your state listed below at least 48 hours before your vaccine appointment to schedule a trip.

A2C will schedule your trips there and back with their contracted transportation providers, which may include a ride-sharing service.

Be sure to note the trip number you receive from the representative making your reservation. If your trip number is not available, you will receive a call back within 24 hours and it will be provided at that time.

At the time of your appointment, you’ll find out how to contact your driver about being picked up.

Customers in the following states can call A2C to schedule their trip(s):

• Alabama, Southern MS: 1 (866) 575-3737
• Arkansas: 1 (866) 780-8554
• Arizona: 1 (800) 285-8818
• Colorado, New Mexico, Utah: 1 (866) 217-7244
• Georgia: 1 (866) 382-0513
• Illinois, Kansas City: 1 (866) 213-7308
• Florida- North: 1 (866) 575-3737
• Florida-Central: 1 (866) 217-5144
• Mid Atlantic-Maryland, Delaware, D.C., Virginia: 1 (888) 235-8146
• North Carolina, South Carolina: 1 (888) 238-4272
• New Jersey, Pennsylvania: 1 (888) 223-7578
• Ohio: 1 (888) 213-2217
• Tennessee, Northern MS (Desoto County): 1 (866) 780-8554
• Texas, Oklahoma City: 1 (866) 214-5126